Actively Recruiting

Age: 18Years - 60Years
FEMALE
Healthy Volunteers
ID05197387

Inflammation in Intrahepatic Cholestasis of Pregnancy

Led by University Hospital, Brest · Updated on 2024-10-16

322

Participants Needed

11

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to understand whether an immune process similar to allograft rejection causes intrahepatic cholestasis of pregnancy (ICP). The study includes pregnant women with and without ICP to explore if immunomodulatory treatments might be helpful. It is an observational study conducted by the University Hospital, Brest, focused on inflammation in ICP. The study involves 322 pregnant women at delivery, divided into two groups: 161 women diagnosed with ICP and 161 without ICP. Blood tests will be performed on both mothers and newborns to measure various biological markers related to inflammation, allograft rejection, and angiogenesis. Placental tissue will also be analyzed to check for chronic inflammation. Participants will provide blood samples and placenta at delivery for detailed analysis. Researchers will compare biological and placental markers between the ICP and non-ICP groups. The main outcome measured is the prevalence of placental chronic inflammation at delivery, alongside levels of biological factors involved in inflammation, rejection, and angiogenesis. The study will monitor these outcomes at delivery and conclude by June 2025.

CONDITIONS

Brief Title

Association of Intrahepatic Cholestasis of Pregnancy and Chronic Placental Inflammation

Who Can Participate

Age: 18Years - 60Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult pregnant woman with a single baby
  • For cases: diagnosed with intrahepatic cholestasis of pregnancy
  • For controls: no diagnosis of intrahepatic cholestasis of pregnancy
Not Eligible

You will not qualify if you...

  • Younger than 18 years old
  • Under legal protection
  • Pregnant with twins or more
  • Delivery before 22 weeks of gestation
  • Medical termination of pregnancy
  • Acute chorioamnionitis, especially due to toxoplasmosis, rubella, CMV, or herpes virus
  • Premature rupture of membranes before 37 weeks of gestation
  • COVID-19 infection in the month before delivery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit at delivery (in-person)

Diagnostic Evaluation

Duration - At delivery

Participants undergo blood tests and placental analysis at delivery to measure biological parameters involved in inflammation, allograft rejection, and angiogenesis, and to assess chronic inflammation in the placenta.

1 visit at delivery (in-person)

Trial Site Locations

Total: 11 locations

1

CHU Angers

Angers, France

Not Yet Recruiting

2

Polyclinique KERAUDREN

Brest, France, 29200

Actively Recruiting

3

CHU de Brest

Brest, France, 29609

Actively Recruiting

4

CHU de Caen

Caen, France, 14000

Actively Recruiting

5

CH de Chambery

Chambéry, France, 75300

Actively Recruiting

6

CH Bretagne Sud

Lorient, France, 56100

Actively Recruiting

7

CHU Nantes

Nantes, France

Actively Recruiting

8

CH de Quimper

Quimper, France, 29000

Actively Recruiting

9

CHU de Rennes

Rennes, France, 35000

Actively Recruiting

10

CH St Brieuc

Saint-Brieuc, France

Actively Recruiting

11

CHU de Tours

Tours, France, 37044

Actively Recruiting

Loading map...

Research Team

C

Claire de Moreuil

P

Philippe Merviel

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Placental gene-expression profiles of intrahepatic cholestasis of pregnancy reveal involvement of multiple molecular pathways in blood vessel formation and inflammation.

QiaoLing Du, YouDong Pan, YouHua Zhang...

https://pubmed.ncbi.nlm.nih.gov/25001852